Bausch Health Companies Inc.

Pharmaceutical Preparations

BHC Pharmaceuticals & Biotechnology People in Pharmaceuticals & Biotechnology SEC CIK 0000885590 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$2.19B
373,990,561 shares Covers every share class this company has on file.
Insiders on file
16
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$522.48M
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
23.84%
insider-held value divided by market capitalisation

What Bausch Health Companies Inc. reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$10.27B
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
$157.00M
FY2025 profit for the period, from this company’s own annual XBRL filings to the SEC
Employees
20,300
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at Bausch Health Companies Inc.

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

Rows are grouped by the role each person reports.

The role comes from the relationship boxes a person ticks on their own insider filings — officer, director, ten per cent owner — not from anything we infer. Somebody who is both an officer and a director appears once, in the combined group, so the row count still matches the figure at the top of this page. Where no filing states a role we say so instead of guessing one.

People who file insider reports against Bausch Health Companies Inc..
Insider Reported role Shares Value Last action
Officers 4
Jean-Jacques Charhon CFO 706,478 $4.63M F Shares withheld for taxes Feb 27, 2026 position reported
Seana Carson General Counsel 616,761 $4.05M S Open-market sale Mar 3, 2026 position reported
Aimee J Lenar EVP 400,335 $2.63M S Open-market sale Aug 19, 2026 position reported
John S Barresi Chief Accounting Officer 192,268 $1.26M F Shares withheld for taxes Feb 28, 2025 position reported
Officers who also sit on the board 3
Thomas Appio Thomas Appio CEO 2,315,374 $15.19M F Shares withheld for taxes Mar 2, 2026 position reported
Frank D Lee CEO 73,795 $484.1K A Grant or award May 22, 2026 position reported
Sandra Leung General Counsel 38,408 $252.0K A Grant or award Jun 30, 2026 position reported
Directors 9
John Paulson John Paulson Board Member 73,615,989 $482.92M A Grant or award Jun 30, 2026 position reported
Amy B. Wechsler Board Member 266,441 $1.75M A Grant or award Jun 30, 2026 position reported
Robert N. Power Board Member 254,723 $1.67M A Grant or award May 22, 2026 position reported
Steven D Miller Board Member 239,224 $1.57M A Grant or award May 16, 2025 position reported
Sarah B. Kavanagh Sarah B. Kavanagh Board Member 236,359 $1.55M A Grant or award May 22, 2026 position reported
Russel C. Robertson Russel C. Robertson Board Member 225,279 $1.48M A Grant or award Mar 29, 2024 position reported
Brett Icahn Board Member 220,280 $1.45M A Grant or award Jun 30, 2025 position reported
Richard Mulligan Board Member 155,616 $1.02M A Grant or award May 16, 2025 position reported
Christian A Garcia Board Member 89,707 $588.5K A Grant or award May 22, 2026 position reported

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Seana Carson sold 6,856 Bausch Health Companies Inc. (BHC) shares for $39,628 on Mar 2, 2026

Unusual change in a direct holding

Flagged because the change that day in the shares this person holds directly was unusually large compared with their own earlier changes. The rows below are the open-market trades reported that day; under each share count is the balance the filing reports after that line.

Seana Carson sold 6,856 Bausch Health Companies Inc. (BHC) shares for $39,628 on Mar 2, 2026
Date Insider Transaction Shares Price Value Filing
Mar 2, 2026 Seana Carson S Open-market sale 6,856 held after: 776,076 $5.78 $39,628 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

John Paulson bought 34,721,118 Bausch Health Companies Inc. (BHC) shares for $312,490,062 on Aug 14, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

John Paulson bought 34,721,118 Bausch Health Companies Inc. (BHC) shares for $312,490,062 on Aug 14, 2025
Date Insider Transaction Shares Price Value Filing
Aug 14, 2025 John Paulson P Open-market purchase 34,721,118 held after: 70,755,869 $9.00 $312,490,062 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Recent insider transactions

Of the 120 rows we hold, 8 are open-market purchases (P) and 9 open-market sales (S) — the only codes we count as buying or selling.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for Bausch Health Companies Inc., newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Aug 19, 2026 Aimee J Lenar S Open-market sale 36,827 $7.03 $258.9K SEC filing ↗
Jul 17, 2026 Aimee J Lenar F Shares withheld for taxes 5,260 $4.83 $25.4K SEC filing ↗
Jul 15, 2026 Aimee J Lenar F Shares withheld for taxes 23,395 $4.89 $114.4K SEC filing ↗
Jun 30, 2026 Amy B. Wechsler A Grant or award 1,394 $4.93 $6.9K SEC filing ↗
Jun 30, 2026 John Paulson A Grant or award 12,677 $4.93 $62.5K SEC filing ↗
Jun 30, 2026 Sandra Leung A Grant or award 6,845 $4.93 $33.7K SEC filing ↗
May 22, 2026 Amy B. Wechsler A Grant or award 45,871 $0.00 $0 SEC filing ↗
May 22, 2026 Eiry Roberts A Grant or award 45,871 $0.00 $0 SEC filing ↗
May 22, 2026 Robert N. Power A Grant or award 45,871 $0.00 $0 SEC filing ↗
May 22, 2026 John Paulson A Grant or award 45,871 $0.00 $0 SEC filing ↗
May 22, 2026 Sandra Leung A Grant or award 45,871 $0.00 $0 SEC filing ↗
May 22, 2026 Frank D Lee A Grant or award 45,871 $0.00 $0 SEC filing ↗
May 22, 2026 Sarah B. Kavanagh A Grant or award 45,871 $0.00 $0 SEC filing ↗
May 22, 2026 Christian A Garcia A Grant or award 45,871 $0.00 $0 SEC filing ↗
May 19, 2026 Frank D Lee S Open-market sale 24,456 $5.43 $132.8K SEC filing ↗
Mar 31, 2026 Sandra Leung A Grant or award 5,946 $5.40 $32.1K SEC filing ↗
Mar 31, 2026 John Paulson A Grant or award 11,574 $5.40 $62.5K SEC filing ↗
Mar 31, 2026 Amy B. Wechsler A Grant or award 1,273 $5.40 $6.9K SEC filing ↗
Mar 3, 2026 Seana Carson S Open-market sale 4,420 $5.77 $25.5K SEC filing ↗
Mar 2, 2026 Seana Carson J Other acquisition or disposition 137,922 $5.95 $820.6K SEC filing ↗
Mar 2, 2026 Seana Carson F Shares withheld for taxes 16,973 $5.95 $101.0K SEC filing ↗
Mar 2, 2026 Seana Carson S Open-market sale 6,856 $5.78 $39.6K SEC filing ↗
Mar 2, 2026 Thomas Appio F Shares withheld for taxes 83,705 $5.95 $498.0K SEC filing ↗
Mar 2, 2026 Thomas Appio J Other acquisition or disposition 1,137,862 $5.95 $6.77M SEC filing ↗
Feb 27, 2026 Seana Carson S Open-market sale 8,388 $5.95 $49.9K SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Corporate ownership links — 1 filer holds a position

Who owns Bausch Health Companies Inc.

Each row is one filer naming this company.

Funds, trusts and other companies file the same ownership forms that executives do. Everything below is taken from those filings, with the position exactly as the filing states it.

Filers holding a position in Bausch Health Companies Inc.

Funds, trusts and companies that disclose an ownership position in Bausch Health Companies Inc..
Owner Reported role Shares Filed
PAULSON & CO. INC. Other,TenPercentOwner 73,255,869

See the full ownership map — every entity that files as an owner of a US public company.

Subsidiaries — 156 legal entities

Subsidiaries of Bausch Health Companies Inc.

156 legal entities named in the subsidiary exhibit filed with this company’s most recent 10-K. . Filing on SEC.gov.

This is not the full list. SEC rules only require a company to name its significant subsidiaries.

What that leaves out

Smaller entities are left out of the exhibit entirely. A short list here means a short exhibit — it does not mean the company owns nothing else. Nothing on this page is inferred: every name below is copied from the filing.

Subsidiaries Bausch Health Companies Inc. names in its most recent annual report, with the place each one is organised.
Subsidiary Organised in
"Bausch Health" Limited Liability Company (aka “Bausch Health” LLC) Ukraine
12279967 Canada Ltd. Canada
12283778 Canada Ltd. Canada
1261229 B.C. Ltd. British Columbia (Canada)
1375209 B.C. Ltd. British Columbia (Canada)
1530065 B.C. Ltd. British Columbia (Canada)
AcuFocus Australia Pty. Ltd Australia
AcuFocus Holdings, Inc. Delaware (US)
AcuFocus, Inc. Delaware (US)
Alden Optical Laboratories, Inc. New York (US)
Amoun Pharmaceutical Romania SRL Romania
Audrey Enterprise, LLC Delaware (US)
B L E P Holding GmbH Germany
B.L.J. Company Limited Japan
Bausch & Lomb (Australia) Pty Limited Australia
Bausch & Lomb (Hong Kong) Limited Hong Kong
Bausch & Lomb (Malaysia) Sdn. Bhd. Malaysia
Bausch & Lomb (New Zealand) Limited New Zealand
Bausch & Lomb (Shanghai) Trading Co., Ltd. China
Bausch & Lomb (Singapore) Private Limited Singapore
Bausch & Lomb (South Africa) (Pty) Ltd South Africa
Bausch & Lomb (Thailand) Limited Thailand
Bausch & Lomb Americas Inc. Delaware (US)
Bausch & Lomb Argentina S.R.L. Argentina
Bausch & Lomb Australia Holdings Pty Limited Australia
Bausch & Lomb Financing LLC Delaware (US)
Bausch & Lomb France France
Bausch & Lomb Gesellschaft m.b.H. Austria
Bausch & Lomb GmbH Germany
Bausch & Lomb Incorporated New York (US)
Bausch & Lomb India Private Limited India
Bausch & Lomb Korea Co. Ltd. Korea
Bausch & Lomb México Holdings, S.A. de C.V. Mexico
Bausch & Lomb México, S.A. de C.V. Mexico
Bausch & Lomb Nordic AB Sweden
Bausch & Lomb Pharma S.A. Belgium
Bausch & Lomb Philippines Inc. Philippines
Bausch & Lomb Poland spółka z ograniczoną odpowiedzialnością (aka Bausch & Lomb Poland sp. z o.o.) Poland
Bausch & Lomb S.A. Spain
Bausch & Lomb Sağlik ve Optik Ürünleri Ticaret A.Ş. Turkey
Bausch & Lomb Swiss AG Switzerland
Bausch & Lomb Taiwan Limited Taiwan
Bausch & Lomb U.K. Limited United Kingdom
Bausch & Lomb-IOM S.p.A. Italy
Bausch + Lomb Corporation Canada
Bausch + Lomb Ireland Limited Ireland
Bausch and Lomb Arabia Regional Headquarters Saudi Arabia
Bausch Foundation, LLC Delaware (US)
Bausch Health Americas, Inc. Delaware (US)
Bausch Health Australia Pty Limited Australia
Bausch Health France France
Bausch Health Hellas Single-Member Pharmaceuticals Société Anonyme Greece
Bausch Health HoldCo Limited Ireland
Bausch Health Ireland Limited Ireland
Bausch Health Korea Co., Ltd. Korea
Bausch Health Limited Liability Company Russia
BAUSCH HEALTH LLC Belarus
Bausch Health LLP Kazakhstan
Bausch Health Magyarország Korlátolt Felelõsségû Társaság Hungary
Bausch Health Perú, S.R.L. Peru
Bausch Health Poland spółka z ograniczoną odpowiedzialnością (aka Bausch Health Poland sp. z o.o.) Poland
Bausch Health Romania SRL Romania
Bausch Health Slovakia s.r.o. Slovakia
Bausch Health Trading DWC-LLC United Arab Emirates
Bausch Health Ukraine Limited Liability Company Ukraine
Bausch Health US, LLC Delaware (US)
Bausch Health, Canada Inc. / Santé Bausch, Canada Inc. Canada
Bausch Pharma Kazakhstan LLP Kazakhstan
Bausch Receivables Funding GP, ULC Canada
Bausch Receivables Funding LP Canada
Bausch RUMO Holdings Limited Liability Company Russia
Bausch+Lomb Netherlands B.V. Netherlands
Bausch+Lomb OPS B.V. Netherlands
Beijing Bausch & Lomb Eyecare Company Ltd. China
Bescon Co., Ltd. Korea
BL Indústria Ótica Ltda. Brazil
Cambridge Pharmaceutical S.A.S. Colombia
Cutting Edge France
Cutting Edge Surgical España Spain
Dr. Gerhard Mann chem.-pharm. Fabrik GmbH Germany
Dr. Mann Limited & Co. KG. Germany
Dr. Robert Winzer Pharma GmbH Germany
ELIOS Vision GmbH Germany
Elios Vision, Inc. Delaware (US)
Emo-Farm spółka z ograniczoną odpowiedzialnością Poland
Farmatech S.A. Colombia
Grundstücksverwaltungsgesellschaft Dr.Gerhard Mann chem.- pharm. Fabrik GmbH Germany
Humax Pharmaceutical S.A. Colombia
ICN Egypt LLC Egypt
ICN Polfa Rzeszow Spółka Akcyjna (aka ICN Polfa SA) Poland
Kedalion Therapeutics, Inc. Delaware (US)
Kestrel Ophthalmics Ltd. United Kingdom
Laboratoire Chauvin France
Laboratorios Fedal, S.A. Mexico
Laboratorios Grossman, S.A. Mexico
Medicis Pharmaceutical Corporation Delaware (US)
Medpharma Pharmaceutical & Chemical Industries LLC United Arab Emirates
Nysco de México, S.A. de C.V. Mexico
Oceanside Pharmaceuticals, Inc . Delaware (US)
OraPharma, Inc. Delaware (US)
Paragon BioTeck, Inc. Nevada (US)
PharmaSwiss Ceská republika s.r.o. Czech Republic
PharmaSwiss d.o.o preduzeće za proizvodnju, unutrašnju, spoljnu trgovinu i zastupanje Beograd (aka PharmaSwiss d.o.o., Beograd) Serbia
PHARMASWISS društvo s ograničenom odgovornošću za trgovinu i usluge (aka PharmaSwiss d.o.o. Croatia) Croatia
PharmaSwiss EOOD Bulgaria
PharmaSwiss SA Switzerland
PharmaSwiss, trgovsko in proizvodno podjetje, d.o.o. Slovenia
Precision Dermatology, Inc. Delaware (US)
Przedsiebiorstwo Farmaceutyczne Jelfa Spółka Akcyjna (aka Jelfa SA) Poland
PT Bausch Lomb Indonesia Indonesia
Salix Pharmaceuticals, Inc. California (US)
Salix Pharmaceuticals, Ltd. Delaware (US)
Santarus, Inc. Delaware (US)
Servicio Integral De Esterilización, S.L.U. Spain
Servicio Integral Hospitalario, S.L.U. Spain
Shandong Bausch & Lomb Freda New Packaging Materials Co., Ltd. China
Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd. China
Sino Concept Technology Limited Hong Kong
Soflens (Proprietary) Limited South Africa
Solta (Shanghai) Health Management Co., Ltd. China
Solta Malaysia Sdn. Bhd. Malaysia
Solta Medical (Thailand) Limited Thailand
Solta Medical Australia Pty Limited Australia
Solta Medical Corporation Canada
Solta Medical Distribution, LLC Delaware (US)
Solta Medical Dutch Holdings B.V. Netherlands
Solta Medical France France
Solta Medical Germany GmbH Germany
Solta Medical Hong Kong Limited Hong Kong
Solta Medical Iberia S.L. (fka Wanakie SA) Spain
Solta Medical Ireland Limited Ireland
Solta Medical Italy S.R.L. Italy
Solta Medical Korea Limited Korea
Solta Medical Philippines Inc. Philippines
Solta Medical Poland spółka z ograniczoną odpowiedzialnością (aka Solta Medical Poland sp. z o.o.) Poland
Solta Medical Singapore Private Limited Singapore
Solta Medical UK Limited United Kingdom
Solta Medical, Inc. Delaware (US)
Solta Taiwan Limited Taiwan
Sterimedix Limited United Kingdom
Synergetics IP, Inc. Delaware (US)
Synergetics, Inc. Missouri (US)
TearLab Corporation (d/b/a Trukera Medical) Delaware (US)
TearLab Research, Inc. (d/b/a Trukera Medical) Delaware (US)
Technolas Perfect Vision GmbH Germany
Tecnofarma, S.A. de C.V. Mexico
Total Titanium, Inc. Illinois (US)
V-BAC Holding Corp. Canada
Valeant Farmacéutica Panamá, S.A. Panama
Valeant Med spółka z ograniczoną odpowiedzialnością Poland
Valeant Servicios y Administración, S. de R.L. de C.V. Mexico
VRX Holdco LLC Delaware (US)
Waicon Vision S.A. Argentina
Whitecap Biosciences LLC Delaware (US)
Wuhan Shibo Zhenmei Technology Co., Ltd. China
Zhejiang Starview Medical Technology Co., Ltd. China
What counts as a subsidiary

A subsidiary is a separate legal entity this company controls; it is not the same thing as a brand, a division or an office. These entities do not file with the SEC in their own right, so there is no separate page to open for them.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from Bausch Health Companies Inc.’s own filings and multiplied by our closing price. Full method.

What that share count means

the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from Bausch Health Companies Inc.’s own SEC filings multiplied by the closing price we hold for the same stock.

Logo: Bausch Health Companies Inc. / Public domain , via Wikimedia Commons ↗ — used here to identify the company. Trademarks remain the property of their owner.